https://retina.news.mail.ru/prev780x440/pic/ec/6b/main42199947_db6d29a8d91bae4abf9afb4d28f08b73.jpg

the Production capacity for the production of vaccines against coronavirus in Russia can be deployed by the beginning of winter, said Dmitry Morozov, General Director of company “Biocad.” The company is developing one of the vaccines COVID-19.

“By the end of autumn — beginning of winter needs to be deployed something production capacity in order to start the vaccine issue”, — said Mr. Morozov on air of TV channel “Saint-Petersburg” (quoted by TASS).

He said that after obtaining permission for a clinical trial, which is scheduled for early August, the introduction of a vaccine into production will depend on many factors. According to Dmitry Morozov, how the vaccine will be to show how long the test is difficult to say.

In late may, the approval of the Ministry of health has received Russia’s first drug against the coronavirus that causes aviewer. It was developed by RDIF and a group of companies “Chemrar”. He will not go on General sale, and will be used only in hospitals and under medical supervision.

Mass vaccination of Russians from the coronavirus can begin in the fall of 2020, said Deputy Prime Minister Dmitry Chernyshenko. This will happen in case of a successful test of a vaccine against SARS-CoV-2 (the virus that causes COVID-19).